Central Trust Company’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565 | Sell |
33
-80
| -71% | -$1.37K | ﹤0.01% | 1393 |
|
|
2025
Q1 | $7.21K | Hold |
113
| – | – | ﹤0.01% | 1161 |
|
|
2024
Q4 | $13.7K | Hold |
113
| – | – | ﹤0.01% | 1048 |
|
|
2024
Q3 | $14.1K | Hold |
113
| – | – | ﹤0.01% | 1012 |
|
|
2024
Q2 | $17.9K | Hold |
113
| – | – | ﹤0.01% | 957 |
|
|
2024
Q1 | $14.6K | Sell |
113
-85
| -43% | -$11K | ﹤0.01% | 1016 |
|
|
2023
Q4 | $19.1K | Hold |
198
| – | – | ﹤0.01% | 959 |
|
|
2023
Q3 | $24K | Sell |
198
-1,109
| -85% | -$134K | ﹤0.01% | 913 |
|
|
2023
Q2 | $150K | Sell |
1,307
-762
| -37% | -$87.3K | ﹤0.01% | 596 |
|
|
2023
Q1 | $285K | Buy |
2,069
+1,702
| +464% | +$235K | 0.01% | 481 |
|
|
2022
Q4 | $47.6K | Buy |
+367
| New | +$47.6K | ﹤0.01% | 778 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | -$13K | – | 1290 |
|
|
2018
Q2 | $13K | Buy |
+100
| New | +$13K | ﹤0.01% | 925 |
|
|
2017
Q4 | – | Sell |
-50
| Closed | -$2K | – | 1362 |
|
|
2017
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 1169 |
|
|
2017
Q2 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1169 |
|